sb 202190 has been researched along with Contact Dermatitis in 2 studies
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole: structure given in first source; inhibits p38 MAP kinase
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Solinski, HJ | 1 |
Dranchak, P | 1 |
Oliphant, E | 1 |
Gu, X | 1 |
Earnest, TW | 1 |
Braisted, J | 1 |
Inglese, J | 1 |
Hoon, MA | 1 |
Takanami-Ohnishi, Y | 1 |
Amano, S | 1 |
Kimura, S | 1 |
Asada, S | 1 |
Utani, A | 1 |
Maruyama, M | 1 |
Osada, H | 1 |
Tsunoda, H | 1 |
Irukayama-Tomobe, Y | 1 |
Goto, K | 1 |
Karin, M | 1 |
Sudo, T | 1 |
Kasuya, Y | 1 |
2 other studies available for sb 202190 and Contact Dermatitis
Article | Year |
---|---|
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
Topics: Animals; Behavior, Animal; Cell-Free System; Dermatitis, Contact; Disease Models, Animal; Ganglia, S | 2019 |
Essential role of p38 mitogen-activated protein kinase in contact hypersensitivity.
Topics: Allergens; Animals; Base Sequence; Dermatitis, Contact; Dinitrofluorobenzene; Disease Models, Animal | 2002 |